Unicycive Therapeutics, Inc. (UNCY)
5.27
-0.23
(-4.18%)
USD |
NASDAQ |
Aug 28, 16:00
5.30
+0.03
(+0.57%)
After-Hours: 17:53
Unicycive Therapeutics Cash from Operations (Quarterly) : -7.604M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.604M |
| March 31, 2026 | -6.241M |
| December 31, 2025 | -8.032M |
| September 30, 2025 | -5.962M |
| June 30, 2025 | -8.42M |
| March 31, 2025 | -8.903M |
| December 31, 2024 | -6.548M |
| September 30, 2024 | -9.252M |
| June 30, 2024 | -6.319M |
| March 31, 2024 | -6.456M |
| December 31, 2023 | -4.439M |
| September 30, 2023 | -4.422M |
| June 30, 2023 | -5.502M |
| March 31, 2023 | -3.92M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.084M |
| September 30, 2022 | -3.563M |
| June 30, 2022 | -3.047M |
| March 31, 2022 | -2.957M |
| December 31, 2021 | -1.403M |
| September 30, 2021 | -3.474M |
| June 30, 2021 | -0.217M |
| March 31, 2021 | -0.673M |
| December 31, 2020 | -0.538M |
| September 30, 2020 | -0.706M |
| June 30, 2020 | -0.142M |
| March 31, 2020 | -0.073M |
| December 31, 2019 | -0.449M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Theriva Biologics, Inc. | -3.085M |
| AbbVie, Inc. | 3.436B |
| Decoy Therapeutics, Inc. | -2.652M |
| Nkarta, Inc. | -24.22M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.023M |
| Cash from Financing (Quarterly) | 14.44M |
| Free Cash Flow | -27.85M |
| Free Cash Flow Per Share (Quarterly) | -0.2825 |
| Free Cash Flow to Equity (Quarterly) | -7.40M |
| Free Cash Flow to Firm (Quarterly) | -7.603M |
| Free Cash Flow Yield | -23.23% |